Marvin Bagley: Everything you need to know

Marvin Bagley

#35 PF

Dallas Mavericks

Status

OUT - Shoulder - Pinched Nerve Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

11.8

6.5

1.0

0.6

0.5

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	60	12	20.0	10.5	6.1	1.4	0.7	0.5	1.0	6	0.4	0.9	46.2%	3.8	6.0	64.1%	4.2	6.9	61.8%	1.6	2.4	66.0%	2.5	3.6	2.1	1.4	-220	66.1%
2024-25	31	2	8.5	4.4	2.7	0.4	0.3	0.3	0.4	1	0.1	0.6	15.8%	1.7	2.8	59.8%	1.8	3.4	51.9%	0.7	1.1	65.7%	1.2	1.5	0.6	0.9	-10	56.0%
2023-24	50	25	21.1	11.7	6.2	1.1	0.7	0.4	1.2	10	0.2	0.5	39.1%	4.6	7.7	59.7%	4.8	8.2	58.6%	1.9	2.5	76.2%	2.6	3.6	1.6	0.9	-137	62.9%
2022-23	42	25	23.6	12.0	6.4	0.9	0.7	0.5	1.1	8	0.5	1.6	28.8%	4.4	7.5	58.1%	4.8	9.1	53.0%	1.9	2.6	75.0%	2.2	4.2	1.9	0.8	-229	58.8%
2021-22	48	25	23.9	11.3	7.0	0.8	0.4	0.5	0.8	7	0.5	2.0	23.7%	4.2	7.3	57.9%	4.7	9.3	50.4%	1.4	2.1	66.3%	2.2	4.9	1.9	0.9	-132	55.1%
2020-21	43	42	25.9	14.1	7.4	1.0	0.5	0.5	1.4	11	0.9	2.5	34.3%	4.9	8.9	55.0%	5.7	11.4	50.4%	1.8	3.1	57.5%	2.5	4.9	2.3	0.7	-87	55.4%
2019-20	13	6	25.7	14.2	7.5	0.8	0.9	0.5	1.4	3	0.3	1.7	18.2%	5.7	11.2	51.0%	6.0	12.8	46.7%	1.9	2.4	80.6%	2.2	5.2	3.3	0.6	-89	51.2%
2018-19	62	4	25.3	14.9	7.6	1.0	1.0	0.5	1.6	19	0.5	1.5	31.3%	5.3	9.8	53.4%	5.7	11.4	50.4%	2.9	4.2	69.1%	2.6	5.0	1.9	0.6	-103	56.2%
Career	349	141	22.0	11.8	6.5	1.0	0.6	0.5	1.1	65	0.4	1.4	30.8%	4.3	7.5	57.3%	4.7	8.9	53.2%	1.8	2.7	68.5%	2.3	4.1	1.9	0.9	-1007	58.2%

Career Averages

PTS

REB

AST

BLK

STL

8.5

3.0

0.0

0.5

1.0

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	2	0	14.0	8.5	3.0	0.0	0.5	1.0	1.5	0	0	0.5	0.5	100.0%	3.5	4.0	87.5%	4.0	4.5	88.9%	0.0	0.0	0.0%	1.0	2.0	1.5	0.0	-20	94.4%
Career	2	0	14.0	8.5	3.0	0.0	0.5	1.0	1.5	0	0	0.5	0.5	100.0%	3.5	4.0	87.5%	4.0	4.5	88.9%	0.0	0.0	0.0%	1.0	2.0	1.5	0.0	-20	94.4%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/16	DET	L 119-98	12	9	5	2	0	0	1	0	0	0.0%	8	4	50.0%	8	4	50.0%	2	1	50.0%	3	2	2.0	-17	1	10	50.7%
10/13	NYK	W 120-103	24	18	11	3	1	2	3	0	0	0.0%	8	7	87.5%	8	7	87.5%	6	4	66.7%	5	6	1.0	+25	3	31	84.6%
10/12	TOR	L 113-112	14	10	7	2	1	0	0	1	0	0.0%	7	3	42.9%	8	3	37.5%	7	4	57.1%	4	3	0.0	+14	1	15	45.1%
Preseason Totals			17.4	12.3	7.7	2.3	0.7	0.7	1.3	0.3	0.0	0.0%	7.7	4.7	60.9%	8.0	4.7	58.3%	5.0	3.0	60.0%	4.0	3.7	1.8	+22	1.7	20.7	60.5%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/8	PHX	L 112-107	26	20	8	2	1	0	2	6	3	50.0%	5	5	100.0%	11	8	72.7%	2	1	50.0%	4	4	1.0	-6	2	25	84.2%
4/7	LAC	L 116-103	26	21	9	1	2	1	0	1	1	100.0%	10	7	70.0%	11	8	72.7%	4	4	100.0%	4	5	0.0	-8	2	32	82.3%
4/5	LAL	W 134-128	21	9	4	0	1	1	0	1	1	100.0%	6	3	50.0%	7	4	57.1%	0	0	0.0%	2	2	0.0	-10	1	11	64.3%
3/27	POR	W 100-93	27	26	9	3	1	1	1	5	3	60.0%	9	8	88.9%	14	11	78.6%	4	1	25.0%	3	6	3.0	+6	5	30	82.5%
3/25	DEN	L 142-135	17	7	3	3	0	0	0	2	0	0.0%	6	3	50.0%	8	3	37.5%	2	1	50.0%	2	1	0.0	+0	3	6	39.4%
3/23	GSW	L 137-131	14	9	0	3	0	0	1	2	1	50.0%	2	2	100.0%	4	3	75.0%	3	2	66.7%	0	0	3.0	-1	2	11	84.6%
3/21	LAC	L 138-131	24	17	7	1	0	0	2	2	2	100.0%	6	5	83.3%	8	7	87.5%	3	1	33.3%	3	4	0.5	-9	1	20	91.2%
3/18	ATL	L 135-120	16	2	7	0	0	1	0	0	0	0.0%	2	1	50.0%	2	1	50.0%	0	0	0.0%	0	7	0.0	-12	0	8	50.0%
3/16	NOP	L 129-111	18	9	9	1	0	1	0	1	1	100.0%	6	3	50.0%	7	4	57.1%	0	0	0.0%	6	3	0.0	-14	4	13	64.3%
3/15	CLE	W 130-120	15	6	5	0	1	0	2	2	1	50.0%	2	1	50.0%	4	2	50.0%	2	1	50.0%	0	5	0.0	-2	4	3	61.5%
3/13	CLE	L 138-105	27	4	4	0	1	0	2	1	0	0.0%	4	2	50.0%	5	2	40.0%	0	0	0.0%	1	3	0.0	-9	1	4	40.0%
3/12	MEM	W 120-112	19	6	9	0	2	0	0	1	0	0.0%	4	3	75.0%	5	3	60.0%	0	0	0.0%	3	6	0.0	+6	3	13	60.0%
3/10	ATL	L 124-112	20	7	6	6	0	0	0	2	1	50.0%	5	2	40.0%	7	3	42.9%	0	0	0.0%	1	5	0.0	+8	1	14	50.0%
3/8	TOR	L 122-92	19	6	7	2	0	0	0	1	0	0.0%	5	2	40.0%	6	2	33.3%	2	2	100.0%	1	6	0.0	-16	1	11	43.6%
2/26	SAC	L 130-121	28	10	9	0	2	0	4	0	0	0.0%	6	5	83.3%	6	5	83.3%	0	0	0.0%	1	8	0.0	-2	4	13	83.3%
2/24	BKN	W 123-114	19	22	5	1	0	0	1	0	0	0.0%	13	10	76.9%	13	10	76.9%	4	2	50.0%	1	4	1.0	+5	3	21	74.5%
2/22	IND	W 134-130	26	12	11	1	0	1	0	0	0	0.0%	9	5	55.6%	9	5	55.6%	4	2	50.0%	2	9	0.0	-6	0	20	55.8%
2/20	MIN	L 122-111	24	15	13	0	1	0	1	2	1	50.0%	7	4	57.1%	9	5	55.6%	4	4	100.0%	7	6	0.0	-5	1	25	69.7%
2/12	LAL	L 124-104	20	7	4	0	0	1	0	1	0	0.0%	6	3	50.0%	7	3	42.9%	2	1	50.0%	0	4	0.0	-18	3	7	44.4%
2/10	PHX	L 120-111	24	9	8	2	0	0	1	0	0	0.0%	4	4	100.0%	4	4	100.0%	4	1	25.0%	4	4	2.0	+7	2	15	78.1%
2/7	SAS	L 138-125	24	16	12	2	4	1	0	1	1	100.0%	13	5	38.5%	14	6	42.9%	7	3	42.9%	8	4	0.0	-19	1	25	46.8%
2/3	NYK	L 132-101	15	11	6	1	0	0	1	0	0	0.0%	7	4	57.1%	7	4	57.1%	4	3	75.0%	2	4	1.0	-4	1	13	62.8%
2/1	SAC	W 116-112	18	15	6	2	1	1	0	1	1	100.0%	7	6	85.7%	8	7	87.5%	0	0	0.0%	2	4	0.0	-10	2	23	93.8%
1/19	LAC	L 110-106	17	6	8	1	2	0	4	0	0	0.0%	5	2	40.0%	5	2	40.0%	2	2	100.0%	7	1	0.3	-15	3	9	51.0%
1/17	DEN	L 121-115	19	14	6	2	1	1	1	0	0	0.0%	6	5	83.3%	6	5	83.3%	9	4	44.4%	3	3	2.0	+2	0	22	70.3%
1/16	SAC	L 128-115	19	8	4	0	0	1	0	1	0	0.0%	4	1	25.0%	5	1	20.0%	8	6	75.0%	1	3	0.0	-8	4	8	46.9%
1/14	LAC	L 119-105	26	15	11	2	0	0	1	1	0	0.0%	9	7	77.8%	10	7	70.0%	2	1	50.0%	5	6	2.0	+4	0	25	68.9%
1/11	PHX	L 112-93	15	6	3	0	1	1	4	0	0	0.0%	4	3	75.0%	4	3	75.0%	0	0	0.0%	1	2	0.0	-16	1	5	75.0%
1/7	PHI	L 131-110	16	9	9	1	1	0	1	2	1	50.0%	8	3	37.5%	10	4	40.0%	0	0	0.0%	5	4	1.0	+6	0	14	45.0%
1/6	ORL	W 120-112	17	12	3	0	1	2	2	0	0	0.0%	6	2	33.3%	6	2	33.3%	8	8	100.0%	0	3	0.0	-15	2	13	63.0%
1/4	MIN	L 141-115	13	6	3	0	0	0	3	0	0	0.0%	3	3	100.0%	3	3	100.0%	0	0	0.0%	1	2	0.0	-23	4	4	100.0%
1/2	BKN	W 119-99	16	12	8	1	0	1	0	0	0	0.0%	5	5	100.0%	5	5	100.0%	2	2	100.0%	2	6	0.0	+18	1	23	102.0%
12/31	MIL	W 114-113	19	9	3	4	0	2	1	1	0	0.0%	5	4	80.0%	6	4	66.7%	1	1	100.0%	0	3	4.0	+6	2	15	69.9%
12/29	PHX	L 115-101	22	7	7	2	3	0	0	1	0	0.0%	4	2	50.0%	5	2	40.0%	4	3	75.0%	3	4	0.0	+11	0	17	51.8%
12/28	MEM	W 116-112	21	14	7	1	0	0	1	0	0	0.0%	8	6	75.0%	8	6	75.0%	2	2	100.0%	3	4	1.0	+0	1	20	78.8%
12/26	TOR	W 138-117	21	6	5	2	1	0	0	0	0	0.0%	4	3	75.0%	4	3	75.0%	0	0	0.0%	0	5	0.0	+7	3	10	75.0%
12/23	CHA	L 126-109	21	15	3	1	1	0	0	0	0	0.0%	7	5	71.4%	7	5	71.4%	6	5	83.3%	2	1	0.0	-5	1	20	77.8%
12/20	MEM	W 130-122	21	16	6	3	0	0	2	1	0	0.0%	12	8	66.7%	13	8	61.5%	0	0	0.0%	5	1	1.5	+7	3	16	61.5%
12/18	SAS	L 119-94	18	13	4	5	0	0	2	1	1	100.0%	5	4	80.0%	6	5	83.3%	4	2	50.0%	2	2	2.5	-5	6	13	83.8%
12/14	IND	W 108-89	31	23	14	1	1	1	2	0	0	0.0%	14	9	64.3%	14	9	64.3%	10	5	50.0%	9	5	0.5	+11	4	28	62.5%
12/12	CLE	L 130-126	33	15	13	4	0	0	2	1	1	100.0%	9	5	55.6%	10	6	60.0%	2	2	100.0%	4	9	2.0	+12	1	27	68.9%
12/6	ATL	L 131-116	19	6	3	2	1	1	1	0	0	0.0%	5	3	60.0%	5	3	60.0%	0	0	0.0%	0	3	2.0	-7	3	6	60.0%
12/4	BOS	L 146-101	25	5	6	0	0	0	1	0	0	0.0%	8	2	25.0%	8	2	25.0%	4	1	25.0%	3	3	0.0	-19	1	0	25.6%
12/2	PHI	L 121-102	26	13	8	1	5	0	1	2	1	50.0%	4	2	50.0%	6	3	50.0%	6	6	100.0%	4	4	1.0	+9	3	24	75.2%
12/1	MIL	W 129-126	29	22	9	1	0	0	0	1	0	0.0%	15	11	73.3%	16	11	68.8%	0	0	0.0%	7	2	0.0	-3	2	26	68.8%
11/19	MIN	L 120-109	30	13	7	3	1	3	2	0	0	0.0%	11	6	54.5%	11	6	54.5%	2	1	50.0%	3	4	1.5	+10	3	19	54.7%
11/16	BKN	L 129-106	16	4	3	1	0	0	1	0	0	0.0%	3	1	33.3%	3	1	33.3%	3	2	66.7%	0	3	1.0	-6	1	4	46.3%
11/12	HOU	L 135-112	12	9	5	1	0	0	0	0	0	0.0%	4	4	100.0%	4	4	100.0%	1	1	100.0%	2	3	0.0	-4	1	15	101.4%
11/10	DET	L 137-135	15	9	2	1	3	3	3	1	1	100.0%	5	3	60.0%	6	4	66.7%	0	0	0.0%	1	1	0.3	+3	1	13	75.0%
11/8	DAL	L 111-105	17	10	5	1	1	0	2	0	0	0.0%	7	4	57.1%	7	4	57.1%	2	2	100.0%	3	2	0.5	-7	1	11	63.5%
11/7	CLE	L 148-115	11	2	7	0	0	0	0	0	0	0.0%	4	0	0.0%	4	0	0.0%	2	2	100.0%	4	3	0.0	-5	1	2	20.5%
11/5	BOS	L 136-107	12	11	5	2	1	0	2	0	0	0.0%	6	5	83.3%	6	5	83.3%	1	1	100.0%	2	3	1.0	-1	2	15	85.4%
11/3	NYK	L 119-102	14	6	7	0	0	0	0	1	0	0.0%	2	2	100.0%	3	2	66.7%	2	2	100.0%	1	6	0.0	-10	3	11	77.3%
11/1	ORL	L 125-94	14	8	3	3	1	0	0	1	0	0.0%	6	4	66.7%	7	4	57.1%	0	0	0.0%	3	0	0.0	-7	3	8	57.1%
10/30	OKC	L 127-108	16	8	3	2	0	0	1	1	1	100.0%	3	2	66.7%	4	3	75.0%	2	1	50.0%	2	1	2.0	-7	3	8	82.0%
10/28	PHI	L 139-134	18	14	7	3	1	2	1	0	0	0.0%	7	6	85.7%	7	6	85.7%	4	2	50.0%	3	4	3.0	-4	3	24	79.9%
10/26	CHA	L 139-113	9	2	1	0	0	0	1	0	0	0.0%	1	1	100.0%	1	1	100.0%	0	0	0.0%	0	1	0.0	-14	2	0	100.0%
10/24	DAL	W 117-107	14	10	4	1	0	0	0	2	1	50.0%	4	3	75.0%	6	4	66.7%	2	1	50.0%	2	2	0.0	-6	4	9	72.7%
10/22	MIL	L 133-120	14	1	3	1	0	1	1	0	0	0.0%	0	0	0.0%	0	0	0.0%	2	1	50.0%	1	2	1.0	-11	2	3	56.8%
Regular Season Totals			20.2	10.6	6.2	1.4	0.7	0.5	1.0	0.8	0.4	48.0%	6.1	3.9	64.1%	6.9	4.3	62.2%	2.4	1.6	66.0%	2.6	3.6	1.4	-211	2.1	17.0	66.4%

Marvin Bagley: Breaking News

Bagley (shoulder) has been ruled out for Sunday's game against the Bulls. Bagley has started each of Dallas' last two games, though he exited Friday's loss to the Spurs after logging just eight minutes. With Daniel Gafford (rest) and P.J. Washington (elbow) also sidelined, Moussa Cisse will likely see an expanded role. Bagley will finish the campaign with averages of 10.5 points, 6.1 rebounds and 1.4 assists in 20.0 minutes per tilt across 60 regular-season appearances (12 starts) between the Mavericks and Wizards.

Bagley (shoulder) is doubtful for Sunday's game versus the Bulls. It appears Bagley will miss the Mavs' regular-season finale after aggravating his shoulder injury during Friday's loss to the Spurs. With both Bagley and Daniel Gafford (rest) expected to sit Sunday, Dwight Powell, Moussa Cisse and Tyler Smith will fill the center minutes for Dallas.

Bagley (shoulder) won't return to Friday's game against the Spurs, Mike Curtis of The Dallas Morning News reports. He'll finish with two points (1-4 FG, 0-2 3Pt), one rebound and one assist in eight minutes. Bagley logged eight minutes in the first quarter but won't return for the remainder of the game due to a left shoulder impingement, which previously cost him three straight games. He should be considered questionable for Sunday's regular-season finale against the Bulls until Dallas offers an update on his status.